Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes

The regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) have made these cells the focus of multiple pre-clinical studies and clinical trials. While the results from these clinical studies have established that MSCs are safe, the efficacy of these cells is not as well-establ...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (204 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03868nam-a2200997z--4500
001 993560446004498
005 20231214133201.0
006 m o d
007 cr|mn|---annan
008 202209s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000080731 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/92076 
035 |a (EXLCZ)995680000000080731 
041 0 |a eng 
100 1 |a Ylostalo, Joni H.  |4 edt 
245 1 0 |a Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes 
246 |a Enhancing Mesenchymal Stem Cells  
260 |a Basel  |b MDPI Books  |c 2022 
300 |a 1 electronic resource (204 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) have made these cells the focus of multiple pre-clinical studies and clinical trials. While the results from these clinical studies have established that MSCs are safe, the efficacy of these cells is not as well-established. In this regard, there have been increased efforts towards generating potentiated/activated MSCs with enhanced therapeutic efficacy. Research on the mechanisms for enhancing MSC potency and efficacy is an area of active study with great potential for translation into clinical settings. The purpose of this book is to bring together recent research from a broad range of topics relating to potentiation strategies for enhancing MSC therapeutic efficacy, including growth factor pre-conditioning, hypoxia, and 3D culture. The research compiled in this book increases the basic understanding of MSC culture techniques and describes some MSC preparations for potential novel therapeutic applications. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a cell therapy 
653 |a immunomodulation 
653 |a polyunsaturated fatty acid 
653 |a CD206 
653 |a phagocytosis 
653 |a mesenchymal stem cells 
653 |a Vadadustat 
653 |a AKB-6548 
653 |a preconditioning 
653 |a priming 
653 |a secretome 
653 |a chemotaxis 
653 |a Wharton’s jelly mesenchymal stem cells 
653 |a umbilical cord 
653 |a oxygen conditions 
653 |a secretory profile 
653 |a neuroprotection 
653 |a mesenchymal stromal cells 
653 |a 3D culture 
653 |a neurospheres 
653 |a spheroids 
653 |a pluripotency 
653 |a neural 
653 |a quiescence 
653 |a mesothelioma 
653 |a malignant pleural mesothelioma (MPM) 
653 |a liver cirrhosis 
653 |a placenta-derived mesenchymal stem cells 
653 |a WKYMVm 
653 |a combination therapy 
653 |a iPSC-derived MSCs 
653 |a iMSC secretome 
653 |a pre-conditioning 
653 |a angiogenesis 
653 |a IFN-γ 
653 |a hypoxia 
653 |a potentiation of iMSC efficacy 
653 |a nanofiber-hydrogel composite 
653 |a spinal cord injury 
653 |a inflammation 
653 |a macrophages 
653 |a secondary injury 
653 |a astrocytes 
653 |a axon growth 
653 |a adipose tissue-derived stem cells (ASCs) 
653 |a autophagy 
653 |a rapamycin 
653 |a 3-methyladenine 
653 |a immunosuppression 
653 |a exosome 
653 |a engineered cardiac patches 
653 |a adipose-derived stem cell 
653 |a paracrine potential 
653 |a osteogenic differentiation 
653 |a hepatocyte growth factor 
653 |a fibroblast growth factor 2 
776 |z 3-0365-4996-X 
776 |z 3-0365-4995-1 
700 1 |a Durand, Nisha C.  |4 edt 
700 1 |a Ylostalo, Joni H.  |4 oth 
700 1 |a Durand, Nisha C.  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:46:04 Europe/Vienna  |f system  |c marc21  |a 2022-09-22 08:09:39 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5340303270004498&Force_direct=true  |Z 5340303270004498  |b Available  |8 5340303270004498